Mitiglinide

ADVERTISEMENT

Identification

Molecular formula
C16H19N3O2
CAS Number
145375-44-4
IUPAC Name
2-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)guanidine
Molecular Weight
267.32g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2560g/cm3
Synonyms
Guanoxan
Interesting facts

Interesting Facts about 2-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)guanidine

2-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)guanidine is a unique compound that has garnered attention in the field of medicinal chemistry and organic synthesis. Here are some intriguing aspects of this compound:

  • Structure and Functionality: This compound features a benzodioxin moiety, a fused bicyclic structure that contributes to its potential biological activity. The presence of the guanidine group may enhance its reactivity and interaction with biological targets.
  • Biological Activity: Research suggests that compounds like 2-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)guanidine may have applications in drug development due to their potential antitumor and antimicrobial properties. The investigation into these activities continues to unfold.
  • Intriguing Applications: This compound could serve as an important scaffold for synthesizing new pharmaceuticals. Its versatility allows for the incorporation of various functional groups, potentially leading to novel therapeutic agents.
  • Chemical Reactions: The guanidine moiety is known for its basicity, making compounds like this one interesting for studying acid-base chemistry and catalytic processes. It may also be involved in nucleophilic reactions.
  • Future Research Directions: Ongoing studies aim to elucidate the mechanism of action and broaden the understanding of how the structural features of this compound contribute to its biological effects.

In conclusion, 2-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)guanidine exemplifies the fascinating intersection of organic chemistry and pharmacology. Its unique structure and potential applications make it a subject of active research and consideration in the development of new therapeutic strategies.

ADVERTISEMENT